Virtu KCG Holdings’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-40,200
Closed -$4.13M 3243
2015
Q4
$4.13M Sell
40,200
-2,100
-5% -$211K 0.07% 182
2015
Q3
$3.95M Buy
42,300
+800
+2% +$77.4K 0.06% 190
2015
Q2
$4.04M Sell
41,500
-1,400
-3% -$140K 0.07% 181
2015
Q1
$4.32M Sell
42,900
-8,700
-17% -$885K 0.09% 151
2014
Q4
$5.4M Buy
51,600
+12,300
+31% +$1.3M 0.09% 128
2014
Q3
$4.19M Sell
39,300
-50,200
-56% -$5.21M 0.08% 180
2014
Q2
$9.36M Sell
89,500
-14,800
-14% -$1.5M 0.15% 81
2014
Q1
$10.2M Sell
104,300
-9,300
-8% -$862K 0.13% 109
2013
Q4
$10.4M Buy
113,600
+26,500
+30% +$2.44M 0.11% 84
2013
Q3
$7.55M Buy
+87,100
New +$7.81M 0.1% 137

Other funds holding JNJ

Virtu KCG Holdings's JNJ Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Johnson & Johnson (JNJ) stake by 21% in Q2 2017, selling an estimated $1.03M and leaving 29,997 shares worth $3.97M. The position accounts for 0.11% of the portfolio, ranked #90.

Virtu KCG Holdings first reported a position in JNJ in Q3 2013 and has held it in 16 quarters since. The position peaked at $11.9M in Q4 2015. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Virtu KCG Holdings held 29,997 shares of Johnson & Johnson worth $3.97M as of Q2 2017.
  • Virtu KCG Holdings sold 8,040 Johnson & Johnson shares in Q2 2017, an estimated $1.03M.
  • Johnson & Johnson made up 0.11% of Virtu KCG Holdings's portfolio in Q2 2017, its #90 holding.
  • Virtu KCG Holdings first reported a position in Johnson & Johnson in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Johnson & Johnson position peaked at $11.9M in Q4 2015.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.